Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (171-180 of 393) with videos related to

Pageof 40
Sort By:
Journal of Neurosurgery|February 5, 2008
Cholesterol granuloma of the lateral ventricle. Case reportPeter M Grossi, Michael J Ellis, Thomas J Cummings, et al.
Expert Opinion on Biological Therapy|February 7, 2020
CAR T cells and checkpoint inhibition for the treatment of glioblastomaSteven H Shen, Karolina Woroniecka, Andrew B Barbour, et al.
Journal of Immunological Methods|June 3, 2018
A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysisAdam M Swartz, Elizabeth Reap, Pamela Norberg, et al.
Expert Opinion on Biological Therapy|April 1, 2011
Bispecific antibodies engage T cells for antitumor immunotherapyBryan D Choi, Mingqing Cai, Darell D Bigner, et al.
Phytotherapy Research : PTR|January 21, 2000
Ethnomedicinally selected plants as sources of potential analgesic compounds: indication of in vitro biological activity in receptor binding assaysJ H Sampson, J D Phillipson, N G Bowery, et al.
Plos One|August 1, 2020
GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibodyPatrick C Gedeon, Michael A Streicker, Teilo H Schaller, et al.
Gynecologic Oncology|December 2, 2006
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patientsJ T Soper, M Spillman, J H Sampson, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastomaPatrick C Gedeon, Bryan D Choi, Tiffany R Hodges, et al.
Journal of Neuroimmunology|October 23, 1997
A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivoD M Ashley, J H Sampson, G E Archer, et al.
Expert Opinion on Biological Therapy|March 10, 2017
Prospect of rindopepimut in the treatment of glioblastomaAladine A Elsamadicy, Pakawat Chongsathidkiet, Rupen Desai, et al.
Pageof 40

Showing results (171-180 of 393) with videos related to

Sort By:
Pageof 40
Journal of Neurosurgery|February 5, 2008
Cholesterol granuloma of the lateral ventricle. Case reportPeter M Grossi, Michael J Ellis, Thomas J Cummings, et al.
Expert Opinion on Biological Therapy|February 7, 2020
CAR T cells and checkpoint inhibition for the treatment of glioblastomaSteven H Shen, Karolina Woroniecka, Andrew B Barbour, et al.
Journal of Immunological Methods|June 3, 2018
A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysisAdam M Swartz, Elizabeth Reap, Pamela Norberg, et al.
Expert Opinion on Biological Therapy|April 1, 2011
Bispecific antibodies engage T cells for antitumor immunotherapyBryan D Choi, Mingqing Cai, Darell D Bigner, et al.
Phytotherapy Research : PTR|January 21, 2000
Ethnomedicinally selected plants as sources of potential analgesic compounds: indication of in vitro biological activity in receptor binding assaysJ H Sampson, J D Phillipson, N G Bowery, et al.
Plos One|August 1, 2020
GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibodyPatrick C Gedeon, Michael A Streicker, Teilo H Schaller, et al.
Gynecologic Oncology|December 2, 2006
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patientsJ T Soper, M Spillman, J H Sampson, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastomaPatrick C Gedeon, Bryan D Choi, Tiffany R Hodges, et al.
Journal of Neuroimmunology|October 23, 1997
A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivoD M Ashley, J H Sampson, G E Archer, et al.
Expert Opinion on Biological Therapy|March 10, 2017
Prospect of rindopepimut in the treatment of glioblastomaAladine A Elsamadicy, Pakawat Chongsathidkiet, Rupen Desai, et al.
Pageof 40